Patrick Soon-Shiong

Los Angeles, CA, United States of America

Patrick Soon-Shiong

Average Co-Inventor Count = 1.8

ph-index = 48

Forward Citations = 7,254(Granted Patents)

Forward Citations (Not Self Cited) = 5,245(Sep 21, 2024)

DiyaCoin DiyaCoin 28.01 

Inventors with similar research interests:



Years Active: 1994-2025

where 'Filed Patents' based on already Granted Patents

331 patents (USPTO):

Title: Patrick Soon-Shiong: Innovator and Prolific Patent Holder

Introduction:

Patrick Soon-Shiong, a renowned entrepreneur and inventor based in Los Angeles, CA, has made significant contributions to the fields of technology, healthcare, and content production. With an impressive patent portfolio and a history of successful ventures, Soon-Shiong has cemented his place as one of the leading innovators in his industry. This article delves into his latest patents, career highlights, notable collaborations, and the impact of his work.

Latest Patents:

Among the numerous patents credited to Patrick Soon-Shiong, two recent innovations stand out. The first patent, "Distributed Command Execution in Multi-Location Studio Environments," focuses on a content production management system. This system enables synchronized execution of commands across various content production entities within a distributed studio environment, improving efficiency and streamlining workflows.

Another noteworthy patent is "Modified NK-92 haNK003 Cells for the Clinic." This invention presents modified populations of NK-92 cells, along with relevant compositions and kits. These modified cells hold immense potential for clinical applications, offering promising methods for their production and utilization.

Career Highlights:

Patrick Soon-Shiong has an extensive career, with notable positions in influential companies. He co-founded and currently serves as Chairman and CEO of Nant Holdingsip, LLC (previously known as NantHealth). Nant Holdingsip is a healthcare technology company that focuses on incorporating data-driven solutions to empower personalized medicine.

Another significant organization Soon-Shiong has been associated with is Abraxis BioScience, LLC (now part of Celgene Corporation). As a founder and CEO of Abraxis BioScience, he played a crucial role in pioneering novel cancer treatments that combined chemotherapy agents with nanoparticle-based delivery mechanisms.

Collaborations:

Throughout his career, Patrick Soon-Shiong has collaborated with experts in various fields to drive innovation. One notable collaborator is Neil P Desai, who has worked alongside Soon-Shiong in developing groundbreaking healthcare technologies and enhancing patient care. Paul A Sandford is another individual who has collaborated with Soon-Shiong, contributing to his innovative projects and entrepreneurial endeavors.

Conclusion:

Patrick Soon-Shiong's prolific patent portfolio, successful career ventures, and fruitful collaborations highlight his significant contributions to technology, healthcare, and content production. His inventions and innovations have the potential to shape industries, enhance efficiency, and improve patient care. As an eminent figure in the innovation landscape, Soon-Shiong continues to inspire and make a lasting impact with his visionary approach and dedication to pushing the boundaries of what is possible.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…